BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15480547)

  • 1. Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
    Asakura H; Sano Y; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
    Intensive Care Med; 2004 Oct; 30(10):1950-5. PubMed ID: 15480547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Sano Y; Omote M; Yoshida T; Ontachi Y; Mizutani T; Kaneda M; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
    Int J Hematol; 2004 May; 79(4):394-9. PubMed ID: 15218973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels.
    Asakura H; Asamura R; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Yoshida T; Miyamoto K; Nakao S
    Thromb Haemost; 2005 Apr; 93(4):724-8. PubMed ID: 15841319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation.
    Slofstra SH; van 't Veer C; Buurman WA; Reitsma PH; ten Cate H; Spek CA
    Crit Care Med; 2005 Jun; 33(6):1365-70. PubMed ID: 15942357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid.
    Asakura H; Sano Y; Yamazaki M; Morishita E; Miyamoto K; Nakao S
    Haematologica; 2004 Jun; 89(6):757-8. PubMed ID: 15194548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
    Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
    Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
    Asakura H; Ichino T; Yoshida T; Suga Y; Ontachi Y; Mizutani T; Kato M; Ito T; Yamazaki M; Aoshima K; Morishita E; Saito M; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):233-9. PubMed ID: 11943937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.
    Izutani W; Fujita M; Nishizawa K; Koga J
    Biol Pharm Bull; 2000 Sep; 23(9):1046-50. PubMed ID: 10993202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
    Asakura H; Aoshima K; Suga Y; Yamazaki M; Morishita E; Saito M; Miyamoto K; Nakao S
    Thromb Haemost; 2001 Feb; 85(2):287-90. PubMed ID: 11246549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist.
    Suga Y; Asakura H; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Nakao S; Miyamoto K
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):593-8. PubMed ID: 15389127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
    Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models.
    Asakura H; Aoshima K; Ichino T; Suga Y; Saito M; Morishita E; Yamazaki M; Ontachi Y; Mizutani T; Kato M; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):301-6. PubMed ID: 11460014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin attenuates hepatic dysfunction by suppressing hepatocellular apoptosis in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Suga Y; Akita F; Yamada S; Morishita E; Asakura H
    Biomed Rep; 2022 Jan; 16(1):5. PubMed ID: 34900254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
    Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
    Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression.
    Yamazaki M; Aoshima K; Mizutani T; Ontachi Y; Saito M; Morishita E; Asakura H; Matsuda T; Triplett DA
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):321-30. PubMed ID: 10493213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats.
    Asakura H; Asamura R; Ontachi Y; Hayashi T; Yamazaki M; Morishita E; Miyamoto KI; Nakao S
    J Thromb Haemost; 2005 May; 3(5):1050-5. PubMed ID: 15869603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation.
    Zhang QY; Guo J; Xu L; Wei Y; Zhou ST; Lu QY; Guo L; Sun QY
    BMC Complement Med Ther; 2022 Sep; 22(1):245. PubMed ID: 36127691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits.
    Hermida J; Montes R; Muñoz MC; Orbe J; Páramo JA; Rocha E
    Am J Hematol; 1999 Jan; 60(1):6-11. PubMed ID: 9883799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Marrow-Derived Mesenchymal Stem Cells-Mediated Protection Against Organ Dysfunction in Disseminated Intravascular Coagulation Is Associated With Peripheral Immune Responses.
    Wang B; Wu S; Wang T; Ma Z; Liu K
    J Cell Biochem; 2017 Oct; 118(10):3184-3192. PubMed ID: 28252221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.